Глава 8
1. Estrogen present in its free, unbound form.
2. Estrogen activity is due to more than one analogue, but usually refers to estradiol. I will use the general term "estrogen" lo include all steroid and related female hormones whose effects parallel estradiol activity. A small amount of testosterone in women also shows the same elTect.
3. Wu AH, Pike MC, and Stram DO. "Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer."]. Nat. Cancer Inst. 91 (1999): 529-534.
4. Bernstein L, and Ross RK. "Endogenous hormones and breast cancer risk." Epidemiol. Revs. 15 (1993): 48-65.
5. Pike MC, Spicer DV, Dahmoush L, et al. "Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk." Epidemiol. Revs. 15 (1993): 17-35.
6. Bocchinfuso WP, Lindzey JK, Hewitt SC, et al. "Induction of mammary gland development in estrogen receptor-alpha knockoul mice." Endocrinology 141 (2000): 2982-2994.
7. Atwood CS, Hovey RC, Glover JP, et al. "Progesterone induces side-branching of the ductal epithelium in the mammary glands of peripubertal mice." j. Endocrinol. 167 (2000): 39-52.
8. Rose DP, and Pruitt BT. "Plasma prolactin levels in patients with breast cancer.• Cancer 48 (1981): 2687-2691.
9. Dorgan JF, Longcope C, Stephenson HE, Jr., et al. "Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk." Cancer Epidemiol Biomarkers Prev 5 (1996):
533- 539.
10. Dorgan JF, Stanczyk FZ, Longcope C, et al. "Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol lo risk of breast cancer in postmenopausal women." Cancer Epidemiol Biomarkers Prev 6 ( 1997):
ll. Thomas HV, Key TJ, Allen DS, et al. "A prospective study of endogenous serum hormone
concentrations and breast cancer risk in post-menopausal women on the island of Guernsey." Brit.]. Cancer 76 (1997): 410-405.
12. Hankinson SE, Willett W, Manson JE, et al. "Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women." j. Nat. Cancer Inst. 90 (1998): 1292-1299.
13. Rosenthal MB, Barnard R), Rose DP, et al. "Effects of a high-complex-carbohydrate, low-fat, low-cholesterol diet on levels of serum lipids and estradiol." Am.]. Med. 78 (1985): 23-27.
14. Adlercreutz H. "Western diet and Western diseases: some hormonal and biochemical mechanisms and associations." Scand.j. Clin. Lab. Invest. 50(Suppl.201) (1990): 3-23.
15. Heber D, Ashley JM, Leaf DA, et al. "Reduction of serum estradiol in postmenopausal women given free access to low-fat high-carbohydrate diet." Nutrition 7 (1991): 137-139.
16. Rose DP, Goldman M, Connolly JM, et al. "High-fiber diet reduces serum estrogen concentrations in premenopausal women." Am.]. Clin. Nutr. 54 (1991): 520-525.
17. Rose DP, Lubin M, and Connolly JM. "Efects of diet supplementation with wheat bran on serum estrogen levels in the follicular and luteal phases of the menstrual cycle." Nutrition 13 (1997): 535-539.
18. Tymchuk CN, Tessler SB, and Barnard RJ. "Changes in sex hormone-binding globulin, insulin, and serum lipids in postmenopausal women on a low-fat, high-fiber diet combined with exercise." Nutr. Cancer 38 (2000): 158-162.
19. Key TJA, Chen J, Wang DY, et al. "Sex hormones in women in rural China and in Britain." Brit.]. Cancer 62 (1990): 631-636.
20. Prentice R, Thompson D, Clifford C, et al. "Dietary fat reduction and plasma estradiol concentration in healthy postmenopausal women."]. Natl. Cancer Inst. 82 (1990): 129-134.
21. Boyar AP, Rose DP, and Wynder EL "Recommenda1ions for the prevention of chronic disease: the application for breast disease." Am.]. Clin. Nutr. 48(3 Suppl) (1988): 896-900.
22. Nandi S, Guzman RC, and YangJ. "Hormones and mammary carcinogenesis in mice, rats and humans: a unifying hypothesis." Proc. National Acad. Sci 92 (1995): 3650-3657.
23. Peto J, Easton DF, Matthews FE, et al. "Cancer mortality in relatives of women with breast cancer, the OPCS study." Int.]. Cancer 65 (1996): 275-283.
24. Colditz GA, Willett W, Hunter DJ, et al. "Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study." JAMA 270 (1993): 338-343.
25. National Human Genome Research Institute. "Leaming About Breast Cancer." Accessed at
http://www.genome.gov/l0000507#ql 26. Futreal PA, Liu Q, Shattuck-Eidens D, et al. "BRCAl mutations in primary breast and ovarian carcinomas." Science 266 (1994): 120-122.
27. Miki Y, Swensen), Shallluck-Eidens D, et al. "A strong candidate for the breast and ovarian cancer susceptibility gene BRCAl." Science 266 (1994): 66-71.
28. Wooster R. Bignell G, Lancaster J, et al. "ldentification of the breast cancer susceptibility gene BRCA2." Nature 378 (1995): 789-792.
29. Tavtigian SV, Simard], Rommens J, et al. "The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds." Nat. Genet. 12 (1996): 333-337.
30. Ford D, Easton D, Bishop DT, et al. "Risks of cancer in BRCAl mutation carriers." Lancet 343 (1994): 692-695.
31. Antoniou A, Pharoah PDP, Narod S, et al. • Average risks of breast and ovarian cancer associated with BRCAl or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies." Am.]. Hum. Genet. 72 (2003): 1117-1130.
32. Newman B, Mu H, Butler LM, et al. "Frequency of breast cancer attributable to BRCAl in a population-based series of American women." JAMA 279 (1998): 915-921.
33. Peto J, Collins N, Barfoot R, et al. "Prevalence of BRCAl and BRCA2 gene mutations in patients with early-onset breast cancer."]. Nat. Cancer Inst. 91 (1999): 943-949.
34. Tabar L, Fagerberg G, Chen HH, et al. "Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial." Cancer 75 (l 995): 2507-2517.
35. Bjurstram N, Bjomeld L, Duffy SW, et al. "The Gothenburg Breast Cancer Screening Trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization." Cancer 80 (1997): 2091-2099.
36. Frisell J, Lidbrink E, Hellstrom L, et al. "Follow-up after 11 years: update of mortality results in the Stockholm mammographic screening trial." Breast Cancer Res. Treat 1997 45 (1997):
263- 270.
37. Greenlee RT, Hill-Harmon MB, Murray T, et al. "Cancer statistics, 2001." CA Cancer]. Clin. 51 (2001): 15-36.
38. Cairns J. "The treatment of diseases and the War against Cancer." Sci. Am. 253 (1985):
31- 39.
39. Cuzick], and Baum M. "Tamoxifen and contralateral breast cancer." Lancet 2 (1985): 282.
40. Cuzick], Wang DY, and Bulbrook RD. "The prevention of breast cancer." Lancet 1 (1986):
83- 86.
41. Fisher B, Costantino JP, Wickerham DL, et al. "Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study."). Nat. Cancer Inst. 90 (1998): 1371-1388.
42. Freedman AN, Graubard BI, Rao SR, et al. "Estimates of the number of U.S. women who could benefit from tamoxifen for breast cancer chemoprevention." J. Nat. Cancer Inst. 95 (2003): 526-532.
43. Powles T, Eeles R, Ashley S, et al. "Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial." Lancet 352 (1998): 98-101.
44. Veronesi U, Maisonneuve P, Costa A, et al. "Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women." Lancet 352 (1998): 93-97.
45. Cuzick J. "A brief review of the current breast cancer prevention trials and proposals for future trials." Eur J Cancer 36 (2000): 1298-1302.
46. Cummings SR, Eckert S, Krueger KA, et al. "The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial." JAMA 281 (1999): 2189-2197.
47. Dorgan JF, Hunsberger S, A., McMahon RP, et al. "Diet and sex hormones in girls: findings from a randomized controlled clinical trial." J. Nat. Cancer Inst. 95 (2003): 132-141.
48. Ornish D, Scherwitz LW, BillingsJH, et al. "Intensive lifestyle changes for reversal of coronary heart disease." JAMA 280 (1998): 2001-2007.
49. Esselsryn CB, Ellis SG, Medendorp SV, et al. "A strategy to arrest and reverse coronary artery disease: a 5-year longitudinal study of a single physician's practice." J. Family Practice 41 (1995): 560-568.
50. Hildenbrand GLG, Hildenbrand LC, Bradford K, et al. "Five-year survival rates of melanoma patients treated by diet therapy after the manner of Gerson: a retrospective review." Alternative Therapies in Health and Medicine l (1995): 29-37.
51. Youngman LD, and Campbell TC. "Inhibition of aflatoxin BI-induced gamma-glutamyl transpeptidase positive (GGT+) hepatic preneoplastic foci and tumors by low protein diets: evidence that altered GGT+ foci indicate neoplastic potential." Carcinogenesis 13 (1992): 1607-1613.
52. Ronai Z, Gradia S, EI-Bayoumy K, et al. "Contrasting incidence of ras mutations in rat mammary and mouse skin tumors induced by anti-benzolc]phenanthrene-3,4-diol-l,2-epoxide." Carcinogensis 15 (1994): 2113-2116.
53. Jeffy BD, Schultz EU, Selmin 0, et al. "Inhibition of BRCA-1 expression by benzo[a]pyrene and diol epoxide." Mol. Carcinogenesis 26 (1999): 100-118.
54. Gammon MD, Santella RM, Neugut Al, et al. "Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts." Cancer Epidemiol Biomarhers Prev 11 (2002): 677-685.
55. Gammon MD, Wolff MS, Neugut Al, et al. "Environmental toxins and breast cancer on Long Island. II. Organchlorine compound levels in blood." Cancer Epidemlol Biomarhers Prev 11 (2002): 686-697.
56. Humphries KH, and Gill S. "Risks and benefits of hormone replacement therapy: the evidence speaks." Canadian Med. Assoc.Joum. 168 (2003): 1001-1010.
57. Writing Group for the Women's Health Initiative Investigators. "Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Jni1ia1ive Randomized Controlled Trial." JAMA 288 (2002): 321-333.
58. Hulley S, Grady D, Bush T, et al. "Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group." JAMA 280 (I 998): 605-613.
59. While this finding is not statistically significant, its consistency with the WHI finding is striking.
60. International Agency for Cancer Research. "Globocan" (accessed 18 October 2002), hnp: //www-dep.iarc/globocan.html."
61. Kinzler KW, and Vogels1ein B. "Lessons from Heredity. Colorectal Cancer." Cell 87 (1996): 159--170.
62. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2000: Cancer Incidence, mortality and prevalence worldwide, Version 1.0. Lyon, France: lARCPress, 2001.
63. Limited version of Ferlay et al. document available at hup://
www.dep.iarc.fr/globocan/ globocan.hlm, last updated on 03/02/2001.
64. Expert Panel. Food, nutrition and the prevenrion of cancer, a global perspective. Washington, DC: American lnsti1U1e for Cancer Research/World Cancer Research Fund, 1997.
65. Armstrong D, and Doll R. "Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices." Inc.]. Cancer 15 (1975):
617- 631.
66. Burkin DP. "Epidemiology of cancer of the colon and the rectum." Cancer 28 (1971): 3-13.
67. Jansen MCJF, Bueno-de-Mesquita HB, Buzina R, et al. "Dietary fiber and plant foods in relation 10 colorectal cancer mortality: The Seven Countries Study." lnl. ]. Cancer 8 I (l 999):
174- 179.
68. Whiteley LO, and Klurfeld OM. "Are dietary fiber-induced alterations in colonic epithelial cell proliferation predictive of fiber's effect on colon cancer?" Nutr. Cancer 36 (2000): 131- 149.
69. Most of these associations were not statistically significant, but the consistency of the inverse association between fiber and colorectal cancer was impressive.
70. Campbell TC, Wang G, Chen J, et al. "Dietary fiber intake and colon cancer mortality in The People's Republic of China." Jn: D. Kri1chevsky, C. Bonfield and J. W Anderson (eds.), Dietary Fiber, pp. 473-480. New York, NY: Plenum Publishing Corporation, 1990.
71. Trock B, Lanza E, and Greenwald P. "Dietary fiber, vegetables, and colon cancer: critical review and meta-analysis of the epidemiologic evidence." ]. Nat. Cancer Inst. 82 (l 990):
650- 661.
72. Howe GR, Benito E, Castelle10 R, et al. "Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies."]. Nat. Cancer Inst. 84 (1992): 1887-1896.
73. Bingham SA, Day NE, Luben R, et al. "Dietary fibre in food and protection against colorectal cancer in the European Prospective lnves1iga1ion into Cancer and Nulrition (EPIC): an observational study." Lancet 361 (2003): 1496-1501.
74. O'Keefe SJD, Ndaba N, and Woodward A. "Relationship between nutritional status, dietary intake panerns and plasma lipoprotein concentrations in rural black South Africans." Hum. Nutr. Clin. Nutr. 39 (1985): 335-341.
75. Sitas E "Histologically diagnosed cancers in South Africa, 1988." 5. African Med.]. 84 (1994 ):
344- 348.
76. O'Keefe SJD, Kidd M, Espitalier-Noel G, et al. "Rarity of colon cancer in Africans is associated with low animal product consumption, not fiber." Am.]. Gastroenrerology 94 (1999): 1373-1380.
77. McKeown-Eyssen G. "Epidemiology of colorectal cancer revisited: are serum 1riglycerides and/or plasma glucose associated with risk?" Cancer Epidemiol Biomarkers Prev 3 (1994): 687-695.
78. Giovannucci E. "Insulin and colon cancer." Cancer Causes and Control 6 (1995): 164-179.
79. Bruce WR, Giacca A, and Medline A. "Possible mechanisms relating diet and risk of colon cancer." Cancer Epidemiol Biomarkers Prev 9 (2000): 1271-1279.
80. Kono S, Honjo S, Todoroki 1, et al. "Glucose intolerance and adenomas of the sigmoid colon in Japanese men (Japan)." Cancer Causes and Control 9 (1998): 441-446.
81. Schoen RE, Tangen CM, Kuller LH, et al. "Increased blood glucose and insulin, body size, and incident colorectal cancer." j. Nat. Cancer Inst. 91 (1999): 1147-1154.
82. Bruce WR, Wolever TMS, and Giacca A. "Mechanisms linking diet and colorectal cancer: the possible role of insulin resistance." Nutr. Cancer 37 (2000): 19-26.
83. Lipkin M, and Newmark H. "Development of clinical chemoprevention trials." j. Nat. Cancer Inst. 87 (1995): 1275-1277.
84. Holt PR, Atillasoy EO, Gilman], et al. "Modulation of abnormal colonic epithelial cell proliferation and differentiation by low-fat dairy foods. A randomized trial." JAMA 280 (1998): 1074-1079.
85. Mobarhan S. "Calcium and the colon: recent findings." Nutr. Revs. 57 (1999): 124-126.
86. Alberts DS, Ritenbuagh C, Story JA, et al. "Randomized, double-blinded, placebo-controlled study of effect of wheat bran fiber and calcium on fecal bile acids in patients with resected adenomatous colon polyps." j. Nat. Cancer Inst. 88 (1996): 81-92.
87. Chen], Campbell TC, Li J, et al. Diet, life-style and mortality in China. A study of the characteristics of 65 Chinese counties. Oxford, UK; Ithaca, NY; Beijing, PRC: Oxford University Press; Cornell University Press; People's Medical Publishing House, 1990.
88. Jass JR. "Colon cancer: the shape of things to come." Gut 45 (1999): 794-795.
89. Burt RW "Colon cancer screening." Gastroenterology 119 (2000): 837-853.
90. Winawer SJ, Zauber AG, Ho MN, et al. "Prevention of colorectal cancer by colonoscopic polypectomy." New Engl.]. Med. 329 (1993): 1977-1981.
91. Pignone M, Rich M, Teutsch SM, et al. "Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force." Ann. Internal Med. 137 (2002): 132-141.
92. Scott????. and Sobol HH. "Prognostic implications of cancer susceptibility genes: Any news?" Recent Results in Cancer Research 151 (1999): 71-84.
93. Lee ML, Wang R-T, Hsing AW, et al. "Case-control study of diet and prostate cancer in China." Cancer Causes and Control 9 (1998): 545-552.
94. Villers A, Soulie M, Haillot 0, et al. "Prostate cancer screening (111): risk factors, natural history, course without treatment." Progr. Urol. 7 (1997): 655-661.
95. Stanford JL. "Prostate cancer trends 1973--1995." Bethesda, MD: SEER Program, National Cancer Institute, 1998.
96. Chan JM, and Giovannucci EL. "Dairy products, calcium, and vitamin D and risk of prostate cancer." Epidemiol. Revs. 23 (2001): 87-92.
97. Giovannucci E. "Dietary influences of 1,25 (OH), vitamin Din relation to prostate cancer: a hypothesis." Cancer Causes and Control 9 (1998): 567-582.
98. Chan JM, Stampfer MJ, Ma J, et al. "Insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 as predictors of advanced-stage prostate cancer." J Natl Cancer Inst 94 (2002): 1099-1109.
99. Doi SQ, Rasaiah S, Tack I, et al. "Low-protein diet suppresses serum insulin-like growth factor-I and decelerates the progresseion of growth hormone-induced glomerulosclerosis." Am. ]. Nephrol. 21 (2001): 331-339.
100. Heaney RP, McCarron DA, Dawson-Hughes B, et al. "Dietary changes favorably affect bond remodeling in older adults." j. Am. Diet. Assoc. 99 (1999): 1228-1233.
101. Allen NE, Appleby PN, Davey GK, et al. "Hormones and diet: low insulin-like growth factor-I but normal bioavailable androgens in vegan men." Brit.]. Cancer 83 (2000): 95-97.
102. Cohen P, Peehl OM, and Rosenfeld RG. "The IGF axis in the prostate." Honn. Metab. res. 26 (1994): 81-84.